Show Search Form
human indexable | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||||
registered interest | |||||||||||||||||||
answer date | |||||||||||||||||||
date | |||||||||||||||||||
date tabled | |||||||||||||||||||
answering body |
|
||||||||||||||||||
question status | Tabled | ||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||
ddp created |
|
||||||||||||||||||
ddp modified |
|
||||||||||||||||||
hansard heading | Radioisotopes: Imports | ||||||||||||||||||
house id | 2 | ||||||||||||||||||
identifier | HL1104 | ||||||||||||||||||
legislature |
|
||||||||||||||||||
parliament number | 57 | ||||||||||||||||||
question first answered |
|
||||||||||||||||||
question text | Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit. | ||||||||||||||||||
session |
|
||||||||||||||||||
session number | 1 | ||||||||||||||||||
tabling member printed |
|
||||||||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL1104 | ||||||||||||||||||
type |
|
||||||||||||||||||
uin | HL1104 | ||||||||||||||||||
version | 1 | ||||||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||||||
answer |
|
||||||||||||||||||
creator |
|
||||||||||||||||||
publisher | 25277 | ||||||||||||||||||
tabling member |
|